Assignable proteins (n=4), where high intensity was associated with poor survival, included proteasome activator complex subunit 1 (PSME1, in STS patients), two histone H4 variants (in LMS patients) and haemoglobin subunit beta (in MFS patients). The gene discussed is PSME1; the disease is telomere syndrome.